← Eichor
Study identifier: NCT06888908 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Changes in Perioperative Blood Volume and Fluid Distribution in Patients Undergoing Primary Total Hip Replacement.

Condition: Hip Arthroplasty Replacement  ·  Sponsor: Copenhagen University Hospital, Hvidovre

PhaseN/A
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Clinical assessment of bleeding and calculation of perioperative blood loss do not provide an accurate estimate of blood volume. This makes rational fluid management difficult, which is of high importance for patient-related outcomes. The availability of carbon monoxide(CO)-rebreathing allows for simple, non-invasive and precise measurement of changes in blood volume. The purpose of the study is to investigate and describe changes in blood volume and fluid distribution perioperative in patients undergoing total hip arthroplasty. Furthermore, to investigate the association between changes in blood volume and incidence of orthostatic insufficiency.

This description comes directly from the study's public registry record.

Talk to the study team

Puk Kristiansen, MD  ·  +4530291189  ·  puk.kristiansen@regionh.dk

Ana-Marija Hristovska, Senior registrar, Ph.D.  ·  ana-marija.hristovska.02@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Hvidovre University HospitalCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06888908